Arcutis Biotherapeutics Inc (ARQT) earnings · rev $376.1M
These earnings events as JSON? API free 100/dayArcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
This ARQT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ARQT revenue for 2025-12-31 was $376.1M. Net income was -$16.1M. Revenue was up 91.3% from 2024-12-31 to 2025-12-31. ARQT currently screens at market cap $1.64B.
When the next ARQT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 91.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ARQT research stays on the stock page; the tape stays on the quote page.
ARQT earnings FAQ
What are ARQT's latest revenue and net income?
Latest cached Arcutis Biotherapeutics Inc (ARQT) revenue for Dec 31, 2025 was $376.1M. Net income was -$16.1M. Statements: https://lician.com/financials/arqt
What is ARQT's latest diluted EPS?
Latest cached Arcutis Biotherapeutics Inc (ARQT) diluted EPS for Dec 31, 2025 was -$0.13.
What period does the latest ARQT earnings print cover?
The latest cached Arcutis Biotherapeutics Inc (ARQT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ARQT revenue change from the prior cached period?
Cached Arcutis Biotherapeutics Inc (ARQT) revenue was up 91.3% from $196.5M (Dec 31, 2024) to $376.1M (Dec 31, 2025). Statements: https://lician.com/financials/arqt
Where are ARQT earnings listed?
Cached earnings facts for Arcutis Biotherapeutics Inc (ARQT) are listed at https://lician.com/earnings/arqt. Statements: https://lician.com/financials/arqt
Not investment advice.